Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation

Takanori Suzuki(Nagoya City University), Hiromi Kataoka(Mizuho (Japan)), Yoshihide Kimura(Nagoya City University), Yasuhito Tanaka(Kumamoto University), Shigeru Kusumoto, Shunsuke Nojiri(Nagoya City University), Shinya Hagiwara(Nagoya City University), Sho Matoya(Toyokawa City Hospital), Kei Fujiwara(Nagoya City University), Atsunori Kusakabe(Japanese Red Cross Nagoya Daini Hospital), Kenji Urakabe(Gifu Prefectural Tajimi Hospital), Tomokatsu Miyaki(Toyokawa City Hospital), Hayato Kawamura(Nagoya City University), Takako Inoue(Kaneka (United States)), Fumihiro Okumura(Gifu Prefectural Tajimi Hospital), Kentaro Matsuura(Nagoya City University), Daisuke Kato(Japanese Red Cross Nagoya Daini Hospital), Atsushi Ozasa(Nagasaki Rousai Hospital), Satoshi Sobue(Kasugai Municipal Hospital), Yoshihito Nagura(Kasugai Municipal Hospital)
Hepatology Research
December 3, 2022
10.1111/hepr.13864
Cited by 3

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Cyclosporin A and Its Analogs Inhibit Hepatitis B Virus Entry Into Cultured Hepatocytes Through Targeting a Membrane Transporter, Sodium Taurocholate Cotransporting Polypeptide (NTCP)
|Hepatology|2013|259
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization
|Proceedings of the National Academy of Sciences|2019|241
Gut Dysbiosis Associated With Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|187
Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID)
|Journal of Biological Chemistry|2013|166